AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

The AIDS Healthcare Foundation said in an advertisement run in various publications that recreational use of the erectile dysfunction treatment manufactured by Pfizer Inc. could lead to behaviors that increase the risk of an HIV infection that leads to AIDS, The Los Angeles Times reported Thursday.

The group said the drug has become popular among gay men who use methamphetamine, a drug that has been tied to risky sexual behavior that could result in HIV infection.

"We call on Pfizer to exercise responsibility by discontinuing marketing to men with mild erectile dysfunction and by initiating an educational campaign on the dangers of Viagra and meth targeting men who have sex with men," the ad said.

Pfizer denied advocating unsafe use of Viagra.

"We've always been committed to the safe and appropriate use of Viagra," said Shontelle Dodson, Pfizer's senior medical director. "We always encourage men to see their physicians for the proper diagnosis."

Copyright 2006 by United Press International

Explore further: Animated tips on how you should and shouldn't approach the visually impaired

Related Stories

Free Lipitor, Viagra, other drugs for jobless

May 14, 2009

(AP) -- Pfizer Inc. is unveiling a new program Thursday that will let people who have lost their jobs and health insurance keep taking some widely prescribed Pfizer medications - including Lipitor and Viagra ...

Recommended for you

Drug and device firms paid $6.5B to care providers

Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.